Cerebrospinal cytokine levels in patients with acute depression J Levine, Y Barak, KNR Chengappa, A Rapoport, M Rebey, V Barak Neuropsychobiology 40 (4), 171-176, 1999 | 449 | 1999 |
Cognitive impairment in probable multiple sclerosis A Achiron, Y Barak Journal of Neurology, Neurosurgery & Psychiatry 74 (4), 443-446, 2003 | 394 | 2003 |
Animal-assisted therapy for elderly schizophrenic patients: A one-year controlled trial Y Barak, O Savorai, S Mavashev, A Beni The American journal of geriatric psychiatry 9 (4), 439-442, 2001 | 367 | 2001 |
Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses A Achiron, U Gabbay, R Gilad, S Hassin-Baer, Y Barak, M Gornish, ... Neurology 50 (2), 398-402, 1998 | 367 | 1998 |
Double-blind, controlled trial of inositol treatment of depression J Levine, Y Barak, M Gonzalves, H Szor, A Elizur, O Kofman, ... American Journal of Psychiatry 152 (5), 792-793, 1995 | 355 | 1995 |
The immune system and happiness Y Barak Autoimmunity reviews 5 (8), 523-527, 2006 | 311 | 2006 |
Validation of the multiple sclerosis international quality of life questionnaire MC Simeoni, P Auquier, O Fernandez, P Flachenecker, S Stecchi, ... Multiple Sclerosis Journal 14 (2), 219-230, 2008 | 259 | 2008 |
Self-stigma, self-esteem and age in persons with schizophrenia P Werner, A Aviv, Y Barak International Psychogeriatrics 20 (1), 174-187, 2008 | 236 | 2008 |
Reduced cancer incidence among patients with schizophrenia Y Barak, A Achiron, M Mandel, I Mirecki, D Aizenberg Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 225 | 2005 |
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study E Shamir, Y Barak, I Shalman, M Laudon, N Zisapel, R Tarrasch, A Elizur, ... Archives of general psychiatry 58 (11), 1049-1052, 2001 | 215 | 2001 |
Late‐onset multiple sclerosis ML Polliack, Y Barak, A Achiron Journal of the American Geriatrics Society 49 (2), 168-171, 2001 | 205 | 2001 |
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves A Achiron, M Polliack, SM Rao, Y Barak, M Lavie, N Appelboim, Y Harel Journal of Neurology, Neurosurgery & Psychiatry 76 (5), 744-749, 2005 | 194 | 2005 |
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study A Achiron, J Chapman, D Magalashvili, M Dolev, M Lavie, E Bercovich, ... PloS one 8 (8), e71058, 2013 | 191 | 2013 |
Melatonin improves sleep quality of patients with chronic schizophrenia E Shamir, M Laudon, Y Barak, Y Anis, V Rotenberg, A Elizur, N Zisapel Journal of Clinical Psychiatry 61 (5), 373-377, 2000 | 185 | 2000 |
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study D Aizenberg, M Sigler, A Weizman, Y Barak International psychogeriatrics 14 (3), 307-310, 2002 | 170 | 2002 |
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial A Achiron, I Kishner, I Sarova-Pinhas, H Raz, M Faibel, Y Stern, M Lavie, ... Archives of neurology 61 (10), 1515-1520, 2004 | 169 | 2004 |
Effect of interferon-beta-1b on cognitive functions in multiple sclerosis Y Barak, A Achiron European neurology 47 (1), 11-14, 2002 | 168 | 2002 |
Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. V Barak, Y Barak, J Levine, B Nisman, I Roisman Journal of basic and clinical physiology and pharmacology 6 (1), 61-69, 1995 | 139 | 1995 |
Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates. Y Barak, A Achiron, A Elizur, U Gabbay, S Noy, I Sarova-Pinhas Journal of Psychiatry and Neuroscience 21 (4), 255, 1996 | 138 | 1996 |
Obstetric complications in individuals diagnosed with autism and in healthy controls D Stein, A Weizman, A Ring, Y Barak Comprehensive psychiatry 47 (1), 69-75, 2006 | 132 | 2006 |